Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
GPs are being advised to switch patients to more potent statins, after an analysis showed practices with higher rates of prescribing had better outcomes in patients and the NHS recommended its simvastatin targets be reviewed.
New research ? using data from all general practices in England ? has found practices which used a higher proportion of low-cost statins (simvastatin and pravastatin) were less likely to achieve a ?cholesterol quality indicator? than those prescribing more atorvastatin and rosuvastatin.
It comes as the NHS Information Centre recommended that the inclusion of low-cost statin prescribing as a QIPP target was put under review.
The body?s December 2012 update on QIPP said it wanted feedback on whether the targets for simvastatin and pravastatin prescribing should be ?remain unchanged, be retired or amended?, particularly in the light of the reduction in cost due to atorvastatin being available generically.
The indicator was calculated for each practice by taking the number of CHD, stroke and diabetes patients with cholesterol below 5mmol/l and dividing it by the total number of patients on those disease registers.
http://www.pulsetoday.co.uk/2000113...371899&spReportId=MTcwMzcxODk5S0#.UMYbF4PsySo
(free registration required)
New research ? using data from all general practices in England ? has found practices which used a higher proportion of low-cost statins (simvastatin and pravastatin) were less likely to achieve a ?cholesterol quality indicator? than those prescribing more atorvastatin and rosuvastatin.
It comes as the NHS Information Centre recommended that the inclusion of low-cost statin prescribing as a QIPP target was put under review.
The body?s December 2012 update on QIPP said it wanted feedback on whether the targets for simvastatin and pravastatin prescribing should be ?remain unchanged, be retired or amended?, particularly in the light of the reduction in cost due to atorvastatin being available generically.
The indicator was calculated for each practice by taking the number of CHD, stroke and diabetes patients with cholesterol below 5mmol/l and dividing it by the total number of patients on those disease registers.
http://www.pulsetoday.co.uk/2000113...371899&spReportId=MTcwMzcxODk5S0#.UMYbF4PsySo
(free registration required)